Effectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland: A test-negative design case-control study (2023)

First Author: Cerqueira-Silva T
Attributed to:  Early Assessment of COVID-19 epidemiology and Vaccine/anti-viral Effectiveness (EAVE II) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pmed.1004156

PubMed Identifier: 36630477

Publication URI: http://europepmc.org/abstract/MED/36630477

Type: Journal Article/Review

Parent Publication: PLOS Medicine

Issue: 1

ISSN: 1549-1277